24/7MN – (NASDAQ:GOVX) GeoVax Labs, Inc. looks ready to pop this morning as it has already traded 2.2 million in volume on 2078 trades as of this post.

The stock was not able to be pushed down at the end of the day by shorts at yesterdays close and looks to open strong today at $2.11

GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization

https://apnews.com/press-release/GlobeNewswire/covid-technology-health-cancer-infectious-diseases-a243e5cd751ff4cfbdd63ff69db4353e

ATLANTA, GA, July 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara (MVA) vectored vaccine against Sudan ebolavirus (SUDV). The study was published in Nature Partner Journals (NPJ) Vaccines.

*editors will be trading in the stock throughout the day as opportunities to buy and sell present themselves